Literature DB >> 11307755

Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL).

C Rutishauser1, S M Sawyer, L Bond, C Coffey, G Bowes.   

Abstract

Current asthma-specific quality of life questionnaires have major conceptual and methodological deficiencies for use in adolescents. The aim of this study was to develop and validate the "Adolescent Asthma Quality of Life Questionnaire (AAQOL)", specifically developed for adolescents with asthma. One-hundred and eleven adolescents with frequent-episodic or persistent asthma aged 12-17 yrs were recruited from three tertiary paediatric asthma clinics. The standardized multi-step method consisted of: 1) item selection including semistructured interviews (n=14); 2) item reduction and validation (n=66); and 3) assessment of reproducibility (n=31). Item reduction was performed applying the clinical impact method. The 32 item AAQOL covers six domains: symptoms, medication, physical activities, emotion, social interaction and positive effects. There was high internal consistency for the six domains (alpha=0.70-0.90) and for the total score (alpha=0.93). Test-retest reliability was high for all domain scores (r=0.76-0.85) and the total score (r=0.90), indicating high reproducibility of the AAQOL. There was high correlation with the paediatric Asthma Quality of Life Questionnaire (rho=0.81) which focuses primarily on symptoms and emotional well-being. There was weak to moderate correlation with clinical parameters of asthma severity (rho=0.25-0.65). The 32-item Adolescent Asthma Quality of Life Questionnaire is a valid, developmentally age-appropriate and dimensionally comprehensive asthma-specific quality of life measure for use in adolescents.

Entities:  

Mesh:

Year:  2001        PMID: 11307755     DOI: 10.1183/09031936.01.17100520

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Longitudinal associations between asthma control, medication adherence, and quality of life among adolescents: results from a cross-lagged analysis.

Authors:  Dana Tiggelman; Monique O M van de Ven; Onno C P van Schayck; Rutger C M E Engels
Journal:  Qual Life Res       Date:  2015-02-26       Impact factor: 4.147

2.  The role of coping strategies in quality of life of adolescents with asthma.

Authors:  Monique O M Van De Ven; Rutger C M E Engels; Susan M Sawyer; Roy Otten; Regina J J M Van Den Eijnden
Journal:  Qual Life Res       Date:  2007-02-01       Impact factor: 4.147

Review 3.  Prevention of food and airway allergy: consensus of the Italian Society of Preventive and Social Paediatrics, the Italian Society of Paediatric Allergy and Immunology, and Italian Society of Pediatrics.

Authors:  Giuseppe di Mauro; Roberto Bernardini; Salvatore Barberi; Annalisa Capuano; Antonio Correra; Gian Luigi De' Angelis; Iride Dello Iacono; Maurizio de Martino; Daniele Ghiglioni; Dora Di Mauro; Marcello Giovannini; Massimo Landi; Gian Luigi Marseglia; Alberto Martelli; Vito Leonardo Miniello; Diego Peroni; Lucilla Ricottini Maria Giuseppa Sullo; Luigi Terracciano; Cristina Vascone; Elvira Verduci; Maria Carmen Verga; Elena Chiappini
Journal:  World Allergy Organ J       Date:  2016-08-18       Impact factor: 4.084

4.  Ubiquitin-Proteasome-Collagen (CUP) Pathway in Preterm Premature Rupture of Fetal Membranes.

Authors:  Xinliang Zhao; Xiaoyan Dong; Xiucui Luo; Jing Pan; Weina Ju; Meijiao Zhang; Peirong Wang; Mei Zhong; Yanhong Yu; W Ted Brown; Nanbert Zhong
Journal:  Front Pharmacol       Date:  2017-06-02       Impact factor: 5.810

5.  A Systematic Review of the Use and Quality of Qualitative Methods in Concept Elicitation for Measures with Children and Young People.

Authors:  Samantha Husbands; Paul Mark Mitchell; Joanna Coast
Journal:  Patient       Date:  2020-06       Impact factor: 3.883

6.  Development and preliminary evaluation of the participation in life activities scale for children and adolescents with asthma: an instrument development study.

Authors:  Eileen K Kintner
Journal:  Health Qual Life Outcomes       Date:  2008-05-28       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.